<unk>  is a nonsteroidal anti-inflammatory drug (NSAID) marketed in the US as an ophthalmic solution (brand names Prolensa and Bromday, prior formulation brand name Xibrom, which has since been discontinued) by ISTA Pharmaceuticals for short-term, local use. Prolensa and Bromday are the once-daily formulation of<unk> , while Xibrom was approved for twice-daily administration. In the European Union, the brand name is Yellox.<unk>  is indicated for the treatment of ocular inflammation and pain after cataract surgery.
Bromfenac
Lufenuron
Flurbiprofen
Flonicamid
Fenvalerate
Terfenadine
Etodolac
Ketorolac